Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

Phase 3 Completed 268 enrolled Sun Pharmaceutical Industries, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the ocular safety, tolerability, and efficacy of topical administration of ISV-303 compared with DuraSite Vehicle.

Timeline

Start: 2012-07
Primary completion: 2013-01
Completion: 2013-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bromfenac	Other / unclassified	0.075 %	—

Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

Summary

Timeline

Drugs

Indications